Europe Bioactive Wound Management Market Growth and Analysis by 2027

The Europe bioactive wound management market is expected to reach US$ 792.10million by 2027 from US$ 465.39million in 2019; it is estimated to grow at a CAGR of 7.0% from 2020 to 2027.

Growing prevalence of wounds and ulcers, and increasing number of surgical procedures are the key factors driving the bioactive wound management market. However, high cost associated with wound care management is the major factor hindering the market growth in Europe.

The wound dressing made by using biomaterials is known as bioactive wound care dressings. These wound dressing materials are designed to be in direct contact with the injury and prevent the chances of further infection. These dressings are made up of both synthetics as well as natural polymers. The rise in diabetes cases, as well as skin injuries due to burns, is expected to fuel the growth of the Europe bioactive wound management market during the estimated period.

The rise in the incidence of chronic injuries and an increased number of surgical procedures are contributing to the growth of the market. The prevalence of surgical site infection is anticipated to rise owing to the growing number of surgeries. As per the Eurostat in 2017, approximately 1.4 million people undergo caesarean sections. For instance, according to international diabetes federation, it has been estimated that there were approximately 7,476,800 cases of diabetes in Germany in 2017. The diabetic patients who undergo certain procedures may get surgical wound. These procedures may cause certain injury in patient in which advanced wound care products plays an important role in healing such wounds. Bioactive wound management products allow rapid healing of surgical site infection; the rising number of surgical procedures is anticipated to surge the demand for these products in the near future.

Moreover, the rising cases of injuries caused by traumatic events and road accidents are one of the major factors driving the market growth. For instance, in 2016, traffic accidents were the fifth cause of death in the EU, with roughly six people out of every 100,000 dying on the roads of the European Union. Additionally, burn injuries are another major cause of developing chronic wounds. Moreover, burn infections have increased in the last few years due to a lack of proper wound management after surgical procedures. As per the German Society for Burn Treatment, about 10,000 to 15,000 people with burn injuries are getting admitted to hospital annually in Germany. Road accidents, burn injuries, and other traumas have increased the number of surgeries. Such cases are expected to surge the demand for rapid wound healing products in the coming years.

After Asia, the European region is highly affected by the outbreak of the COVID-19 pandemic. Countries like Italy, Spain, the UK, Germany, France, Russia, and Switzerland are highly affected.Therefore, to control the spread of COVID-19, governments of various countries have implemented lockdown. However, the services for chronic wound care have reduced dramatically. Furthermore, the trade for wound care management has been reduced for the time being, which has resulted in a loss for various companies.

Rest of Europe Bioactive wound management Market,Revenue and Forecast to 2027 (US$ Mn)

EUROPE BIOACTIVE WOUND MANAGEMENT MARKET SEGMENTATION

By Product

• Alginates
• Collagen-based Dressing
• Antimicrobial Dressings
• Bioengineered Skin Substitutes
• Hydrocolloids

By Application

• Burn Wounds
• Surgical Wounds
• Pressure Ulcers
• Diabetic Foot Ulcers
• Venous Leg Ulcers

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

By Country

• Germany
• UK
• France
• Italy
• Spain

Company Profiles

• Smith & Nephew
• Hartman Group
• Tissue Regenix Group
• Coloplast Group
• ConvaTec Group Plc

Europe Bioactive Wound Management Report Scope